Alnylam Pharmaceuticals Inc's drug for a rare hereditary disease won U.S. regulatory approval on Friday, becoming the first approved treatment from a new class of medicines that use gene silencing technology.


30


Reuters

Latest News

USA Today: OnPolitics Today: 'A plot gone awry'

USA Today: Manny the Masher, Manny the Miscreant & Macho Manny

USA Today: OnPolitics Today: 'A plot gone awry'

USA Today: Michigan NCAA tournament hero Jordan Poole rips Michigan State campus: 'It's trash'

USA Today: NFL: Odell Beckham Jr. greeted Randy Moss with moon celebration

USA Today: Hurricane Willa expected to devastate Mexico's Pacific coast

Daily Mail: US warships sail through Taiwan Strait

Daily Mail: Kieran Foran and his new wife, a mother-of-six, 39, post adoring messages to each other

CNBC: These stocks may be sacrificed in a cold war with China

CNBC: Hasbro CEO: Earnings, tariffs and esports

CNBC: 'We don't expect to see any major tariff situation,' says Hasbro CEO, as company moves production out of China

CNBC: Shares of downtrodden IBM 'ready to roar higher': Charts

CNBC: Fed Chair Powell 'like a racehorse with blinkers on'

CTV News: Vancouver mayoral candidate admits defeat, congratulates winner

Reuters: Trump says he believes Khashoggi's death was 'a plot gone awry': USA Today

Reuters: Trump says he believes Khashoggi's death was 'a plot gone awry': USA Today

Times of Israel: Gazans scale back border protests as Egypt renews cease-fire efforts

WashingtonPost: Bible Museum admits some of its Dead Sea Scrolls are fake

NewYorkTimes: Bodega Robbery Ends in Fatal Shooting of Unarmed Man

CBS: Both Obama and Trump to campaign in Wisconsin this week

CBC: Building playgrounds and relationships: Ahmadiyya Muslims and Standing Buffalo celebrate new play structure

ABC: WATCH: High-stakes Mega Millions game now worth $1.6 billion

USA Today: Bills QB Anderson to start against Patriots; Allen ruled out

11 Related Articles, between 2018-08-10 and 2018-08-08